<unk>  (), sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis type I (NF-1), a genetic disorder of the nervous system causing tumors to grow on nerves. It is taken by mouth. Common side effects include headache, abdominal pain and other problems of the gastrointestinal tract, fatigue, muscle pain, as well as dry skin and other skin problems.<unk>  was approved for medical use in the United States in April 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Selumetinib
Binimetinib
Cobimetinib
Pralsetinib
Lestaurtinib
Axitinib
Mobocertinib
Gefitinib